These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 26836177)
1. Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives. Wang J; Tan L; Yu JT J Alzheimers Dis; 2016; 50(4):927-45. PubMed ID: 26836177 [TBL] [Abstract][Full Text] [Related]
2. Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions. Andrieu S; Coley N; Lovestone S; Aisen PS; Vellas B Lancet Neurol; 2015 Sep; 14(9):926-944. PubMed ID: 26213339 [TBL] [Abstract][Full Text] [Related]
3. Advances in the prevention of Alzheimer's disease and dementia. Solomon A; Mangialasche F; Richard E; Andrieu S; Bennett DA; Breteler M; Fratiglioni L; Hooshmand B; Khachaturian AS; Schneider LS; Skoog I; Kivipelto M J Intern Med; 2014 Mar; 275(3):229-50. PubMed ID: 24605807 [TBL] [Abstract][Full Text] [Related]
4. Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives. Ontaneda D; Fox RJ; Chataway J Lancet Neurol; 2015 Feb; 14(2):208-23. PubMed ID: 25772899 [TBL] [Abstract][Full Text] [Related]
5. Evolving early (pre-dementia) Alzheimer's disease trials: suit the outcomes to the population and study design. Doody RS J Nutr Health Aging; 2010 Apr; 14(4):299-302. PubMed ID: 20306000 [TBL] [Abstract][Full Text] [Related]
6. Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies. Lista S; Dubois B; Hampel H J Nutr Health Aging; 2015 Feb; 19(2):154-63. PubMed ID: 25651440 [TBL] [Abstract][Full Text] [Related]
7. EU/US/CTAD Task Force: Lessons Learned from Recent and Current Alzheimer's Prevention Trials. Aisen P; Touchon J; Amariglio R; Andrieu S; Bateman R; Breitner J; Donohue M; Dunn B; Doody R; Fox N; Gauthier S; Grundman M; Hendrix S; Ho C; Isaac M; Raman R; Rosenberg P; Schindler R; Schneider L; Sperling R; Tariot P; Welsh-Bohmer K; Weiner M; Vellas B J Prev Alzheimers Dis; 2017; 4(2):116-124. PubMed ID: 29186281 [TBL] [Abstract][Full Text] [Related]
8. Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J; Ritter A; Zhong K J Alzheimers Dis; 2018; 64(s1):S3-S22. PubMed ID: 29562511 [TBL] [Abstract][Full Text] [Related]
9. Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease. Carrillo MC; Brashear HR; Logovinsky V; Ryan JM; Feldman HH; Siemers ER; Abushakra S; Hartley DM; Petersen RC; Khachaturian AS; Sperling RA Alzheimers Dement; 2013 Mar; 9(2):123-131.e1. PubMed ID: 23411394 [TBL] [Abstract][Full Text] [Related]
10. Prevention studies in Alzheimer's disease: progress towards the development of new therapeutics. Coley N; Gallini A; Andrieu S CNS Drugs; 2015 Jul; 29(7):519-28. PubMed ID: 26188654 [TBL] [Abstract][Full Text] [Related]
11. Lessons learned from failed and discontinued clinical trials for the treatment of Alzheimer's disease: future directions. Carlsson CM J Alzheimers Dis; 2008 Oct; 15(2):327-38. PubMed ID: 18953117 [TBL] [Abstract][Full Text] [Related]
13. Using cognitive decline in novel trial designs for primary prevention and early disease-modifying therapy trials of Alzheimer's disease. Darby D; Brodtmann A; Woodward M; Budge M; Maruff P Int Psychogeriatr; 2011 Nov; 23(9):1376-85. PubMed ID: 21477408 [TBL] [Abstract][Full Text] [Related]